Trial site
Synexus Polska Sp z o o
- 23running trials
- 16closed trials
The trials here
What the 40 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease6 trials
- Obesity6 trials
- Fatty liver disease (MASLD/MASH)4 trials
- Atopic dermatitis (eczema)3 trials
- Epilepsy3 trials
- Psoriasis3 trials
- Type 2 diabetes3 trials
- Ulcerative colitis3 trials
- Chronic kidney disease2 trials
- Lupus (SLE)2 trials
- Osteoporosis2 trials
- Asthma1 trial
- and 6 more
- Phase
- Phase 327 trials
- Phase 210 trials
- Phase 2/33 trials
- Status
- Completed15 trials
- Active, not recruiting13 trials
- Recruiting10 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Biohaven Therapeutics Ltd.3 trials
- Akero Therapeutics Inc.2 trials
- Ascletis Pharma (China) Co. Ltd.2 trials
- AstraZeneca2 trials
- Cinclus Pharma Holding AB2 trials
- and 26 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Enrolling by invitation
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Chronic spontaneous urticaria1 recruiting
- Coeliac disease1 recruiting
- Epilepsy1 recruiting
- Heart failure1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
Recruiting
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Completed
Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis
Completed
Completed
Completed
Completed
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Terminated
Completed
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026